Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 11, 1996, Pages 2293-2301

  Ma, Ding ^a   Luyten, Gregorius P ^b   Luider, Theo M ^b   Jager, Martine J ^c   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

melanoma; metastasis; NM23; tumor suppressor gene; uvea

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CELL TRANSPLANTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; MOUSE; NORTHERN BLOTTING; NUDE MOUSE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UVEA; UVEA MELANOMA;

ANIMALS; ANTERIOR EYE SEGMENT; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; DNA PROBES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM TRANSPLANTATION; NUCLEOSIDE-DIPHOSPHATE KINASE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0029836813     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert D. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239-251.
2. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer. 1983;52:334-336.
3. Char D. Metastatic choroidal melanoma. Am J Ophthalmol. 1978;86:76-80.
4. Donoso LA, Berd D, Augsburger JJ, Mastrongelo MJ, Shields JA. Metastatic uveal melanoma: pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol. 1985;103:796-798.
5. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci. 1992;33:1919-1922.
6. McCurdy J, Gamel J, McLean I. A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from routine H&E slides. Pathol Res Pract. 1991;187:1025-1027.
7. Reese AB. Tumors of the Eye. 3rd Edition. Hagerstown, MD: Harper & Row; 1976:174-262.
8. Paul EV, Parnell L, Fraker M. Prognosis of malignant melanoma of the choroid and ciliary body. Int Ophthalmol Clin. 1962;2:387-402.
9. Callender GR. Malignant melanotic tumors of the eye: A study of histologie types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931; 36:131-140.
10. Steeg PS. Genetic control of the metastatic phenotype. Semin Cancer Biol. 1991;2:105-110.
11. Royds JA, Rees RC, Stephenson TJ. NM23 - a metastasis suppressor gene? J Pathol. 1994;173:211-212.
12. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200-204.
13. Hennessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst. 1991;83:281-285.
14. Floørenes VA, Aamdal S, Myklebost O, et al. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992;52:6088-6091.
15. Haut M, Steeg PS, Wilson JKV, Markowitz SD. Induction of NM23 gene expression in human colonie neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst. 1991:83:712-716.
16. Higashiyama M, Doi O, Yokouchi H, et al. Immunohistochemical analysis of NM23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br J Cancer. 1992;66:533-536.
17. Niederkorn JY, Mellon J, Pidherney M, Mayhew E, Anand R. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Curr Eye Res. 1993;12:347-358.
18. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci. 1989;30:829-834.
19. + cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunotherap. 1994; 38:399-405.
20. Luyten GPM, Mooy CM, De Jong PTVM, Hoogeveen AT, Luider TM. A chicken embryo model to study the growth of human uveal melanoma. Biochem Biophys Res Comm. 1993;192:22-29.
21. Ksander BR, Rubsamen P, Olsen K, Cousins S, Streilein JW. Studies of tumor-infiltrating lymphocytes from a choroidal melanoma. Invest Ophthalmol Vis Sci. 1991;32:3198-3208.
22. Albert DM, Ruzzo MA, McLaughlin MA, Robinson NL, Craft JL, Epstein J. Establishment of cell lines of uveal melanoma. Invest Ophthalmol Vis Sci. 1984; 25:1284-1299.
23. Waard-Siebinga I De, Blom D-J R, Griffioen M, et al. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer. 1995;62:155-161.
24. Harning R, Szalay, J. Ocular metastasis of in viva and in vitro derived syngeneic murine melanoma. Invest Ophthalmol Vis Sci. 1987;28:1599-1604.
25. Harning R, Szalay J. A treatment for metastasis of murine ocular melanoma. Invest Ophthalmol Vis Sci. 1988;29:1505-1510.
26. Knisely TL, Niederkorn JY. Immunologic evaluation of spontaneous regression of intraocular murine melanoma. Invest Ophthalmol Vis Sci. 1990;31:247-257.
27. Wilson SE, He Y-G, Lloyd SA. EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756-1765.
28. Ma D, Niederkorn JY. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice. Invest Ophthalmol Vis Sci. 1995;36:1067-1075.
29. Aryee DNT, Ströbel T, Kos K, et al. High nm23-H1/ NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance. Int J Cancer. 1995;64:104-111.
30. Barnes R, Masood S, Barker E, et al. Low nm23 protein expression in infiltrating ductal breast carcinomas correlated with reduced patient survival. Am J Pathol. 1991;139:245-250.
31. Hirayama R, Sawai S, Takagi Y, et al. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl. Cancer Inst. 1991;83:1249-1250.
32. Gilles A-M, Presecan E, Vonica A, Lasca I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991;266:8784-8789.
33. Stryer L. G proteins. A family of signal transducers. Annu Rev Cell Biol. 1986;2:391-419.
34. Nickerson JA, Wells WW. The microtubule-associated nucleoside diphosphate kinase. J Biol Chem. 1984; 259:11297-11304.
35. Leone A, Flatow U, King CR, et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell. 1991;65:25-35.
36. Alizadeh H, Ma D, Bellingham D, et al. Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas. Curr Eye Res. 1995;14:449-458.
37. McLean IW, Zimmerman LE, Evans RM. reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978; 86:557-564.
38. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? An unanswered question. Br J Ophthamol. 1968; 62:420-425.
39. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma: II: A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthamol. 1992;110:245-150.